GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Glenmark Pharmaceuticals GLENMARK.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

2,671.10

+3.13%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹167.11bn

FY2017FY2026

Net income

₹13.62bn

FY2017FY2026

Free cash flow

₹20.87bn

FY2017FY2026

Shareholders' equity

₹105.12bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹167.11bn₹133.22bn₹118.13bn₹115.83bn₹123.05bn₹109.44bn₹106.41bn₹98.65bn₹91.03bn₹91.86bn
Gross profit₹115.97bn₹84.33bn₹68.10bn₹73.26bn₹73.26bn₹66.17bn₹64.32bn₹59.36bn₹55.51bn₹61.64bn
Operating income₹40.23bn₹14.93bn₹5.52bn₹3.00bn₹15.79bn₹16.85bn₹13.15bn₹14.27bn₹12.61bn₹14.60bn
Net income₹13.62bn₹10.47bn−₹15.02bn₹2.97bn₹9.42bn₹9.70bn₹7.76bn₹9.25bn₹7.74bn₹9.16bn
Diluted earnings per share48.2637.08-53.2110.5333.3734.3627.5132.7727.4732.44

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹199.08bn₹160.50bn₹143.59bn₹193.72bn₹170.83bn₹156.04bn₹146.85bn₹132.96bn₹130.21bn₹122.12bn
Cash and short-term investments—₹17.38bn₹16.58bn₹12.89bn₹14.11bn₹11.38bn₹11.11bn₹9.38bn₹12.33bn₹10.56bn
Total liabilities₹93.96bn₹72.00bn₹65.11bn₹98.98bn₹79.97bn₹85.39bn₹86.14bn₹76.90bn₹74.32bn₹72.73bn
Debt—₹24.73bn₹12.31bn₹46.08bn₹39.62bn₹49.86bn₹51.86bn₹44.49bn₹46.39bn₹47.24bn
Shareholders' equity₹105.12bn₹88.49bn₹78.48bn₹94.74bn₹90.87bn₹70.65bn₹60.71bn₹56.05bn₹55.89bn₹49.39bn
Shares outstanding282m282m282m282m282m282m282m282m282m282m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹34.45bn−₹8.28bn−₹4.57bn₹6.26bn₹11.09bn₹11.31bn₹13.92bn₹13.24bn₹16.48bn₹6.57bn
Capital spending−₹13.58bn−₹7.51bn−₹9.15bn−₹6.08bn−₹7.90bn−₹7.75bn−₹9.31bn−₹12.37bn−₹10.45bn−₹7.49bn
Free cash flow₹20.87bn−₹15.78bn−₹13.72bn₹183.0m₹3.19bn₹3.56bn₹4.61bn₹870.0m₹6.03bn−₹911.0m
Dividends paid−₹1.41bn−₹704.4m−₹1.18bn−₹1.37bn−₹927.0m−₹704.5m−₹685.5m−₹678.8m−₹678.8m−₹678.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹39.32bn₹37.60bn₹39.01bn₹60.47bn₹32.64bn₹32.56bn₹33.88bn₹34.34bn
Gross profit₹26.86bn₹25.88bn₹26.06bn₹47.82bn₹22.49bn₹21.67bn₹23.03bn₹23.64bn
Operating income₹6.32bn₹6.15bn₹5.75bn₹10.34bn₹1.54bn₹746.9m₹4.77bn₹4.82bn
Net income₹4.83bn₹3.01bn₹4.03bn₹6.10bn₹468.7m₹46.5m₹3.48bn₹3.54bn
Diluted earnings per share17.1110.6814.2821.621.660.1612.3312.55
Cash from operations———₹28.36bn—−₹8.28bn—−₹7.83bn
Capital spending———−₹5.00bn—−₹7.51bn—−₹2.46bn
Free cash flow———₹23.35bn—−₹15.78bn—−₹10.29bn
Total assets—₹199.08bn—₹190.02bn—₹160.50bn—₹152.35bn
Cash and short-term investments———₹29.15bn—₹17.38bn—₹20.39bn
Debt———₹7.78bn—₹6.99bn—₹1.40bn
Shareholders' equity—₹105.12bn—₹95.82bn—₹88.49bn—₹84.46bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.0%8.8%8.1%
Operating income137.6%19.0%13.2%
Net income66.1%7.0%6.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin66.7%63.9%62.7%62.7%
Operating margin18.4%11.9%12.6%13.2%
Net margin8.0%2.3%4.1%5.9%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings52.154.9-30.380.912.715.317.910.625.218.3
Price to sales4.24.33.92.11.01.41.31.02.11.8

Dividends and splits

Per share, in the currency the company pays

Paid for 17 years. Last went ex-dividend on 3 Oct 2025.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year5.002.502.502.502.502.502.002.00
  • 2-for-1 split · 10 Sept 2007
  • 2-for-1 split · 4 Mar 2005
  • 5-for-1 split · 23 Oct 2003

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.